Cellply
Advances personalized cancer treatment
Cellply has raised €16M across 5 funding rounds from 10 investors, most recently a round in May 2026. Based in Bologna, Italy; founded 2013; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€16M
€15,560,000
Funding rounds
5
Investors
10
distinct backers
Active since
2014-03
latest 2026-05
Funding by year
EUR raised per year · 2026 YTDCellply — funding by year — interactive chart.
Data table
| Cellply — funding by year | |
|---|---|
| 2014 | €2.0M |
| 2021 | €2.0M |
| 2022 | €810k |
| 2023 | €3.6M |
| 2026 | €7.2M |
Signals
High confidenceRaise-next likelihood27
base rate 30% for Other
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood20
base rate 11% (2+ rounds)
- ▲ 5 rounds raised
- ▲ Recently backed by strong-exit-track investors
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
5 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-05-13 | Other | €7.2M | CDP Venture Capital,ENEA Tech e Biomedical,Existing Shareholders | View deal → |
| 2023-09-29 | Other | €3.6M | LIFTT,Recomec,Schia Ventures | View deal → |
| 2022-01-26 | Other | €810k | Schia Ventures | View deal → |
| 2021-12-15 | Other | €2.0M | Indaco Venture Partners,Italian Angels for Growth,LIFTT,Meta Partners,Recomec | View deal → |
| 2014-03-01 | Seed | €2.0M | Italian Angels for Growth,Zernike Meta Ventures | View deal → |